Literature DB >> 29103088

Left ventricular functions in children with newly diagnosed Graves' disease. A single-center study from Upper Egypt.

Kotb Abbass Metwalley1, Hekma Saad Farghaly2, Abdelrahman Abdelhamid3.   

Abstract

This study aimed to evaluate the left ventricular (LV) functions in a cohort of children with Graves' disease (GD). This is a cross-sectional case-control study. It included 36 children with GD and 36 healthy children matched for age and gender. Thyroid hormones (TSH, FT4, and FT3) and anti-thyroid autoantibodies [anti-thyroid peroxidase (anti-TPO), thyrotropin receptor (TRAbs), and thyroglobulin antibodies] were measured. Conventional and tissue Doppler imaging (TDI) echocardiographies were used to assess left ventricular systolic and diastolic functions. LV mass index (LVMI) and myocardial performance index (MPI) were also measured. Compared to healthy children, conventional echocardiography of patients with GD revealed higher LVMI (P = 0.001) indicating LV hypertrophy but normal LV functions while TDI revealed lower Em/Am ratio indicating LV diastolic dysfunction (P = 0.001). Significant correlations were reported between FT4 with LVMI (P = 0.05), Em/Am (P = 0.01), and MPI (P = 0.01). In multivariate analysis, a positive correlation was identified between FT4 with MPI (OR = 1.17; 95% CI = 1.09-1.15; P = 0.001).
CONCLUSIONS: Children with newly diagnosed GD may have significant subclinical changes in LV structure and function (diastolic and global). TDI is more sensitive than conventional Doppler in detecting LV dysfunction. These findings highlight the importance of early monitoring of children with GD for left ventricular mass index and diastolic function. What is Known: • There is an increased risk for cardiac abnormalities in children with Graves' disease (GD). • Limited studies assessed left ventricular function in patients with GD. What is New: • Children with newly diagnosed GD may have significant subclinical changes in left ventricular structure and functions. • Children with newly diagnosed GD should be monitored for left ventricular mass index and diastolic function.

Entities:  

Keywords:  Diastolic function; Echocardiography; Graves’ disease; Left ventricular function; Left ventricular mass index; Myocardial performance index; Tissue Doppler imaging

Mesh:

Year:  2017        PMID: 29103088     DOI: 10.1007/s00431-017-3039-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  30 in total

1.  Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts.

Authors:  T H Brix; K O Kyvik; K Christensen; L Hegedüs
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients.

Authors:  B Biondi; E A Palmieri; S Fazio; C Cosco; M Nocera; L Saccà; S Filetti; G Lombardi; F Perticone
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

Review 3.  Grave's disease 1835-2002.

Authors:  A P Weetman
Journal:  Horm Res       Date:  2003

4.  Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' disease: a 120 months prospective study.

Authors:  Carlo Cappelli; Elena Gandossi; Maurizio Castellano; Claudio Pizzocaro; Barbara Agosti; Andrea Delbarba; Ilenia Pirola; Elvira De Martino; Enrico Agabiti Rosei
Journal:  Endocr J       Date:  2007-08-03       Impact factor: 2.349

5.  Tei index as a method of evaluating left ventricular diastolic dysfunction in acute myocardial infarction.

Authors:  Nearchos S Nearchou; Alexandros K Tsakiris; Marios D Tsitsirikos; Emmanouil N Karatzis; Maria D Lolaka; Konstantina D Flessa; Dimitrios Th Bogiatzis; Panagiotis D Skoufas
Journal:  Hellenic J Cardiol       Date:  2005 Jan-Feb

6.  The systolic function of the left ventricle of the heart in patients with hyperthyroidism during therapy.

Authors:  C Marcisz; E J Kucharz; G Jonderko; J Wojewódka
Journal:  Pol Arch Med Wewn       Date:  2001-02

7.  Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis.

Authors:  G W Ching; J A Franklyn; T J Stallard; J Daykin; M C Sheppard; M D Gammage
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

8.  Cardiac changes in subclinical and overt hyperthyroid women: retrospective study.

Authors:  M Donatelli; P Assennato; V Abbadi; M L Bucalo; V Compagno; S Lo Vecchio; L Messina; V Russo; A Schembri; V Torregrossa; G Licata
Journal:  Int J Cardiol       Date:  2003-08       Impact factor: 4.164

9.  The evaluation of diastolic dysfunction with tissue Doppler echocardiography in women with subclinical hypothyroidism and the effect of L-thyroxine treatment on diastolic dysfunction: a pilot study.

Authors:  Gulbanu Erkan; Aycan Fahri Erkan; Mustafa Cemri; Selma Karaahmetoglu; Mustafa Cesur; Atiye Cengel
Journal:  J Thyroid Res       Date:  2011-08-08

Review 10.  Cardiac hypertrophy and thyroid hormone signaling.

Authors:  Wolfgang Dillmann
Journal:  Heart Fail Rev       Date:  2009-01-06       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.